Navigation Links
Campbell Alliance Trade and Distribution Practice to Speak at CBI's Commercial Contracts and Chargeback Management Conference
Date:6/10/2008

RALEIGH, N.C., June 10 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that executives from the firm's Trade and Distribution Practice will present at the Center for Business Intelligence (CBI) 4th Annual Commercial Contracts and Chargeback Management for Manufacturers and Wholesalers Conference to be held June 19-20, 2008, at the Hyatt Regency Philadelphia at Penn's Landing.

Tony Lanzone, Vice President, and Doug Linton, a member of the firm's Executive Advisory Group, will present a session on Friday, June 20, at 2:15pm, titled "A New Look at Contracting and Chargebacks in Light of New Data Feeds-Maximizing EDI 844 and 867 Reports." Attendees of the session will learn how to maximize use of 844 and 867 data, including how to apply this data to

-- Forecast chargebacks, returns, and account reserves

-- Identify duplicate and negative chargebacks

-- Identify product demand scenarios (spikes, availability) and general

contracting priorities

Campbell Alliance's Trade and Distribution Practice, under Mr. Lanzone's leadership, helps pharmaceutical and biotech companies develop strategies and address business challenges related to product distribution, maximize the effectiveness of trade programs, and more effectively work with retail and specialty pharmacies.

Tony Lanzone has more than 15 years of experience in the healthcare industry, ranging from work in a top-five pharmaceutical company to management consulting in both the hospital and pharmaceutical sectors. Prior to joining Campbell Alliance, he served as a senior director in Premier's HealthCare Informatics division. Mr. Lanzone earned his MBA from the Graduate School of Business at the College of William & Mary.

Doug Linton has worked in the pharmaceutical distribution field for more than 20 years, with experience in both senior management and consulting. Mr. Linton spent much of his career with Cardinal Health, a global manufacturer and distributor of medical and surgical supplies and technologies, where he was instrumental in transforming the business from a small regional player to a highly profitable national drug wholesaler. Mr. Linton spent the majority of his tenure at Cardinal in senior management, reporting to the founder and CEO, and developed several very profitable new business units for the company. Mr. Linton has also worked as a senior executive with two regional drug wholesalers and spent time as a consultant, advising more than 20 pharmaceutical companies in the areas of trade and distribution.

Mr. Linton graduated with a degree in Economics with honors from the College of Wooster (Ohio) and an MBA from Carnegie Mellon University.

For more information on the CBI 4th Annual Commercial Contracts and Chargeback Management for Manufacturers and Wholesalers Conference, please visit https://www.cbinet.com/show_conference.cfm?confCode=PC08036&field=summary.

Executives from Campbell Alliance are invited to speak at many conferences in the US and Europe each year. For a full listing of events, please refer to the company's online conference calendar at http://www.campbellalliance.com/pressroom/eventcalendar.cfm.

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

CONTACT:

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Dec. 7, 2016  Vyriad Inc. announced today the ... company,s Board of Directors. "We are delighted ... our business and develop our oncolytic viruses as the ... Stephen Russell , MD, PhD, CEO of Vyriad. ... our vision and passion for making a difference for ...
(Date:12/7/2016)... DIEGO , December 7, 2016 ... in the International Journal of Molecular Sciences a team of ... 1 ] have demonstrated that expression of NR2F6 ...  These scientists tested for NR2F6 in patient,s cervical cancer tissue ... their tumors. "This is an interesting study and ...
(Date:12/7/2016)... , ... December 07, 2016 ... ... opening applications to an early access program for SmartBiome -- a novel ... with the simultaneous specific enrichment and detection of hundreds of different genes. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... largest privately-held contract pharmaceutical development and manufacturing organisation, today announced the ... company combining a leading CRO and the industry’s only Contract Commercial Organization ...
Breaking Biology Technology:
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/22/2016)... -- According to the new market research report "Biometric System ... Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and ... expected to grow from USD 10.74 Billion in 2015 to reach USD ... 2022. Continue Reading ... ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
Breaking Biology News(10 mins):